Maxime Desmarets

机构：Inserm, Centre Hospitalier Universitaire de Besançon, Methodology and Quality of Life Unit in Oncology, Clinical Investigation Center Plurithematic Tours, Établissement Français du Sang, Université de Franche-Comté · ORCID：0000-0002-3801-5297

发表论文 94 篇 · 总被引 1583 次 · h-index 20

代表论文

• Pre-emptive TIPS for gastric variceal bleeding in patients with cirrhosis (GAVAPROSEC): an open-label randomised clinical trial (2025 · ˜The œLancet. Gastroenterology & hepatology · 被引 23)
• Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial (2025 · EBioMedicine · 被引 21)
• Effect of rifaximin in patients with severe cirrhosis and ascites: A randomized double-blind placebo-controlled trial (2025 · Journal of Hepatology · 被引 19)
• Areal bone mineral density, trabecular bone score and 3D-DXA analysis of proximal femur in psoriatic disease (2024 · Frontiers in Medicine · 被引 7)
• Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection (2024 · Human Genetics and Genomics Advances · 被引 6)
• Comparison of high-risk HPV detection by the AmpFire® HPV Screening 16/18/HR technique (Atila Biosystems) and the hybrid capture 2 test (Qiagen) (2024 · Molecular Biology Reports · 被引 4)